Michael A – Interview 22
Michael was first diagnosed with breast cancer in 2000. Had a mastectomy and 11-12 lymph nodes removed, followed by radiotherapy and tamoxifen. Found another lump in 2008 which was also breast cancer. Had a lumpectomy, followed again by radiotherapy and Arimadex
When Michael first found a lump on his chest he was immediately suspicious; he immediately thought that it was breast cancer and he went along the next day to see his doctor. A (female ) friend of his had recently had breast cancer. He was referred quickly and soon had a mastectomy as a day patient. Two weeks later he returned to have 11 or 12 lymph nodes removed. He experienced some lymphoedema after the surgery. There was then a delay of a few weeks before he started 15 sessions of radiotherapy. He was prescribed tamoxifen which he took until just after he was discharged in 2006.
In 2008 he found another lump on his other breast. This time he had a lumpectomy and the removal of just 2 lymph nodes which he described as a piece of cake; in comparison with his first experience. He again had radiotherapy, followed by a course of Arimadex.
Because he had had two separate diagnoses of breast cancer, he was offered genetic testing, and he was not surprised when that showed that he had BRCA2. He was advised that this put him at higher risk of also developing prostate cancer and it was suggested that he should have further checks. These showed signs of early pre-cancerous changes in his prostate. Somewhat reluctantly he went on to have a prostatectomy which he was recovering from at the time of his interview. One of his sons had gone on to have testing for BRCA2 which thankfully proved negative. Michael did not know about his biological family history because he was adopted.
Michael has a close and supportive family and good support from his religious faith and his friends in church. He felt very well treated throughout his treatment for his breast cancer and well supported by family and medical staff through the whole process (in contrast with his experience of prostate cancer surgery). He thought that there was quite a positive difference in the information that he was given at the time of his second diagnosis in 2008 in comparison with 2000. In 2000 he had felt that the literature he was given was all aimed at women, but by 2008 things had improved and the material was less gender-specific. Most of his treatment was in the hospital that he worked in and he felt it was a real advantage to be treated in a familiar environment. He had found it helpful to be able to tell people about his breast cancer and to be able to talk about it.